GlassScriptPrepare for your visit
Erin C Cobry
Pediatric Endocrinology · Aurora, CO · NPI 1174966030
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$14,898.36
in general payments reported to CMS, 2019-2025 · $773 in 2025
The $773 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Who reported paying
General payments only, top 6 by amount.
- Dexcom, INC. $13,299.72
- Abbott Laboratories $417.31
- Beta Bionics, INC. $368.08
- Tandem Diabetes Care, INC. $244.21
- Medtronic, INC. $241.03
- Insulet Corporation $132.20
Drugs and devices associated with these payments
Dexcom G7 Gss (161) Ilet Bionic Pancreas Dexcom G6 Transmitter Freestyle Libre Minimed 780g T:Slim X2 Insulin Pump With Control-Iq Omnipod Tzield Afrezza Freestyle Libre 3
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Erin Cobry listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/4223548/erin-c-cobry